stoxline Quote Chart Rank Option Currency Glossary
  
Clover Health Investments, Corp. (CLOV)
2.5752  -0.005 (-0.19%)    12-08 13:20
Open: 2.61
High: 2.62
Volume: 1,419,269
  
Pre. Close: 2.58
Low: 2.545
Market Cap: 1,329(M)
Technical analysis
2025-12-08 12:45:38 PM
Short term     
Mid term     
Targets 6-month :  3.64 1-year :  4.34
Resists First :  3.12 Second :  3.72
Pivot price 2.44
Supports First :  2.16 Second :  1.79
MAs MA(5) :  2.58 MA(20) :  2.46
MA(100) :  2.81 MA(250) :  0
MACD MACD :  -0.1 Signal :  -0.2
%K %D K(14,3) :  80.1 D(3) :  84.7
RSI RSI(14): 47.3
52-week High :  4.86 Low :  2.11
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ CLOV ] has closed below upper band by 25.1%. Bollinger Bands are 43.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 7 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 2.67 - 2.69 2.69 - 2.7
Low: 2.54 - 2.55 2.55 - 2.57
Close: 2.55 - 2.58 2.58 - 2.6
Company Description

Clover Health Investments, Corp. operates as a medicare advantage insurer in the United States. The company through its Clover Assistant, a software platform that provides preferred provider organization and health maintenance organization health plans for medicare-eligible consumers. It also focuses on non-insurance businesses. Clover Health Investments, Corp. was incorporated in 2014 and is based in Franklin, Tennessee.

Headline News

Thu, 04 Dec 2025
Why Is Clover Health Investments (CLOV) Down 11.6% Since Last Earnings Report? - Yahoo Finance

Sun, 30 Nov 2025
Clover Health: Smart Money Should Be Accumulating Ahead Of 2026 GAAP Profits (CLOV) - Seeking Alpha

Wed, 05 Nov 2025
Further Upside For Clover Health Investments, Corp. (NASDAQ:CLOV) Shares Could Introduce Price Risks After 36% Bounce - simplywall.st

Tue, 04 Nov 2025
Clover Health Investments, Corp. (CLOV) Reports Break-Even Earnings for Q3 - Yahoo Finance

Tue, 04 Nov 2025
Clover Health Investments Corp (CLOV) Q3 2025 Earnings Call Highlights: Strong Membership ... - Yahoo Finance

Mon, 03 Nov 2025
Clover Health Investments Corp (CLOV) Q3 2025: Everything You Need To Know Ahead Of Earnings - Yahoo Finance

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Underperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Medical - Healthcare Plans
Shares Out 424 (M)
Shares Float 404 (M)
Held by Insiders 3.3 (%)
Held by Institutions 32.3 (%)
Shares Short 43,480 (K)
Shares Short P.Month 54,070 (K)
Stock Financials
EPS -0.11
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0.66
Profit Margin -3.3 %
Operating Margin -5 %
Return on Assets (ttm) -6 %
Return on Equity (ttm) -16.9 %
Qtrly Rev. Growth 50 %
Gross Profit (p.s.) 0.88
Sales Per Share 4.17
EBITDA (p.s.) -0.14
Qtrly Earnings Growth 0 %
Operating Cash Flow -85 (M)
Levered Free Cash Flow -9 (M)
Stock Valuations
PE Ratio -23.41
PEG Ratio 0
Price to Book value 3.9
Price to Sales 0.61
Price to Cash Flow -12.92
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android